These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 22358361

  • 1. In vitro activities of antifungal agents alone and in combination against fluconazole-susceptible and -resistant strains of Candida dubliniensis.
    Scheid LA, Mario DA, Kubiça TF, Santurio JM, Alves SH.
    Braz J Infect Dis; 2012; 16(1):78-81. PubMed ID: 22358361
    [Abstract] [Full Text] [Related]

  • 2. Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.
    Alves IA, Bandeira LA, Mario DA, Denardi LB, Neves LV, Santurio JM, Alves SH.
    Mycopathologia; 2012 Sep; 174(3):215-21. PubMed ID: 22528740
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
    Alves SH, Da Matta DA, Azevedo AC, Loreto ES, Boff E, Santurio JM, Guarro J.
    Mycoses; 2006 May; 49(3):220-5. PubMed ID: 16681814
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
    Pfaller MA, Messer SA, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR.
    J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G, Carrillo-Muñoz AJ, Arévalo MP, Salgado J, Alonso-Vargas R, Rodrigo JM, Ruesga MT, Valverde A, Pemán J, Cantón E, Martín-Mazuelos E, Pontón J.
    Chemotherapy; 2000 Mar; 46(6):395-401. PubMed ID: 11053905
    [Abstract] [Full Text] [Related]

  • 6. In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates.
    Moraes RC, Carvalho AR, Lana AJ, Kaiser S, Pippi B, Fuentefria AM, Ortega GG.
    Pharm Biol; 2017 Dec; 55(1):406-415. PubMed ID: 27931150
    [Abstract] [Full Text] [Related]

  • 7. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G.
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [Abstract] [Full Text] [Related]

  • 8. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
    Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003
    [Abstract] [Full Text] [Related]

  • 9. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC, Gil J, Ramírez de Ocáriz I, Benito R, Rezusta A.
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [Abstract] [Full Text] [Related]

  • 10. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    Nguyen MH, Yu CY.
    J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
    [Abstract] [Full Text] [Related]

  • 11. Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
    Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A.
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1593-6. PubMed ID: 15793148
    [Abstract] [Full Text] [Related]

  • 12. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT, Cañadas J, García-Martos P, Marín P, García-Tapia A, Rodríguez J.
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [Abstract] [Full Text] [Related]

  • 13. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E, Parras P, Lozano MC.
    Chemotherapy; 1992 Sep; 38(5):335-9. PubMed ID: 1337508
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB, Mario DA, Loreto ÉS, Santurio JM, Alves SH.
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
    Barchiesi F, Falconi Di Francesco L, Scalise G.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
    Madhavan P, Jamal F, Chong PP, Ng KP.
    Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
    Arias A, Arévalo MP, Andreu A, Rodríguez C, Sierra A.
    Mycoses; 1994 Aug; 37(7-8):285-9. PubMed ID: 7739661
    [Abstract] [Full Text] [Related]

  • 18. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN, Chandy R, Khan ZU.
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
    Cuenca-Estrella M, Díaz-Guerra TM, Mellado E, Monzón A, Rodríguez-Tudela JL.
    Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):432-5. PubMed ID: 10442422
    [Abstract] [Full Text] [Related]

  • 20. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
    Sojakova M, Liptajova D, Borovsky M, Subik J.
    Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.